BGC > Product Search > N-[5-(1,1-Dimethylethyl)-3-isoxazolyl]-N'-(4-{7-[2-(4-morpholinyl)ethoxy]imidazo[2,1-b]benzothiazol-2-yl}-phenyl)-urea | 950769-58-1

Molecular Formula: C29H32N6O4S
Molecular Weight: 560.66718

Molecular Formula: C29H32N6O4S
Molecular Weight: 560.66718

Molecular Formula: C29H32N6O4S
Molecular Weight: 560.66718

Molecular Formula: C29H32N6O4S
Molecular Weight: 560.66718

Molecular Formula: C29H32N6O4S
Molecular Weight: 560.66718

Description :
This active molecular also known as AC220 and AC010220, is developed as a new second-generation FLT3 inhibitor for Flt3(ITD/WT) with IC50 of 1.1 nM/4.2 nM, ten fold more selective for Flt3 than KIT, PDGFRα, PDGFRβ, RET, and CSF-1R. Now Quizartinib is in Phase-III clinical trials in Acute myeloid leukaemia.

• Molecular Weight :560.67
• Purity :98%

Molecular Formula :
C29H32N6O4S
Canonical SMILES :
O=C(NC1=CC=C(C2=CN3C(SC4=CC(OCCN5CCOCC5)=CC=C34)=N2)C=C1)NC6=NOC(C(C)(C)C)=C6
InChI :
1S/C29H32N6O4S/c1-29(2,3)25-17-26(33-39-25)32-27(36)30-20-6-4-19(5-7-20)22-18-35-23-9-8-21(16-24(23)40-28(35)31-22)38-15-12-34-10-13-37-14-11-34/h4-9,16-18H,10-15H2,1-3H3,(H2,30,32,33,36)
InChIKey :
CVWXJKQAOSCOAB-UHFFFAOYSA-N
Solubility :
Soluble in DMSO
Appearance :
Solid powder
Application :
treatment of Acute myeloid leukaemia(AML).
Storage : -20°C Freezer
Synonyms :
1-(5-(tert-butyl)isoxazol-3-yl)-3-(4-(7-(2-morpholinoethoxy)benzo[d]imidazo[2,1-b]thiazol-2-yl)phenyl)urea; AC220; AC 220; AC-220; AC010220; AC-010220; AC 010220; AC010220; Quizartinib

More details are to be found here